Cytokine signatures in atherosclerotic claudicants

Journal of Surgical Research

Volumn 111, Issue 2, 2003, Pages 215-221

  DePalma, Ralph G ^a,c   Hayes, Virginia W ^b   Cafferata, H Treat ^a   Mohammadpour, Hamid A ^a   Chow, Bruce K ^a   Zacharski, Leo R ^a   Hall, Mark R ^a  

^a Department of Surgery   (United States)

^b VA Sierra Nevada Health Care System   (United States)

^c Department of Surgery ^*  (United States)

Author keywords

Atherosclerosis; Cytokines; Ferritin; Inflammation; Iron

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; CYTOKINE; FERRITIN; FIBRINOGEN; GLUCOSE; HEMOGLOBIN A1C; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; TRANSFERRIN; TUMOR NECROSIS FACTOR ALPHA; URIC ACID;

ADULT; AGE; AGED; ANALYTIC METHOD; ARTICLE; ATHEROSCLEROSIS; CHI SQUARE TEST; CHOLESTEROL BLOOD LEVEL; CLAUDICATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; ENZYME AMPLIFIED SENSITIVITY ASSAY; FERRITIN BLOOD LEVEL; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; PERIPHERAL VASCULAR DISEASE; PHLEBOTOMY; PRIORITY JOURNAL; RANK SUM TEST; REGRESSION ANALYSIS; SMOKING; TRANSFERRIN BLOOD LEVEL;

EID: 0038354947     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-4804(03)00075-1     Document Type: Article

References (49)

1. Ross R. Atherosclerosis is an inflammatory disease. Am. Heart J. 138:1999;S419.
2. Frostegard J., Ulfgren A.-K., Nyberg P., Hedin U., Swedenborg J., Andersson U. Hansson G. K. Cytokine expression in advanced human atherosclerotic plaques dominance of proinflammatory (Th1) and macrophage-stimulating cytokines . Atherosclerosis. 145:1999;33.
3. Desfaits A.C., Serri O., Renier G. Normalization of lipid peroxides, monocytes adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment. Diabetes Care. 21:1998;487.
4. Winkler G., Lakatos P., Salamon F., Nagy Z., Speer G., Kovacs M., Harmos G., Dworak O., Cseh K. Elevated serum TNF-alpha level as a link between endothelial dysfunction and insulin resistance in normotensive obese patients. Diabet. Med. 16:1999;207.
5. Fazio S., Linton M.F. The inflamed plaque Cytokine production and cholesterol balance in the vessel wall . Am J Cardiol. 88:(2-A):2001;122E.
6. Gerszten R.E., Mach F., Sauty A., Rosensweig A., Luster A.D. Chemokines, leukocytes, and atherosclerosis. J. Lab. Clin. Med. 136:2000;87.
7. Salonen J.T., Korpela H., Nyyssonen K., Porkkala E., Tuomainen T.P., Belcher J.D., Jacobs D.R. Jr, Salonen R. Lowering of body iron stores by bloodletting and oxidation resistance of serum lipoproteins a randomized crossover trial in male smokers . J. Intern. Med. 237:1995;161.
8. Howes P.S., Zacharski L.R., Sullivan J., Chow B. Role of stored iron in atherosclerosis. J. Vasc. Nurs. 18:2000;109.
9. Peach H.G., Bath N.E. Post-test probability that men in the community with raised plasma ferritin concentrations are hazardous drinkers. J. Clin. Path. 11:1999;853.
10. Fletcher L.M.L. Alcohol and iron One glass of red or more? J. Gastroenterol. Hepatol. 11:1996;1039.
11. Gerlag D.M., Ransone L., Tak P.P., Han Z., Palanki M., Barbosa M.S., Boyle D., Manning A.M., Firestein G.S. The effect of T cell -specific NF-kappa B inhibitor on in vitro cytokine production and collagen-induced arthritis. J. Immunol. 165:2000;1652.
12. Iacobelli M., Wachsman W., McGuire K.L. Repression of IL-2 promoter activity by the novel basic leucine zipper p21SNFT protein. J. Immunol. 165:2000;860.
13. Charles P., Elliott M.J., Davis D., Potter A., Kalden J.R., Antoni C., Breedveld F.C., Smolen J.S., Eberl G., de Woody K., Feldmann M., Maini R.N. Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNFa therapy in rheumatoid arthritis. J. Immunol. 163:1999;1521.
14. Nakagawa S., Koomen C.W., Bos J.D., Teunissen M.B.M. Differential modulation of human epidermal Langerhans cell maturation by ultraviolet B radiation. J. Immunol. 163:1999;5192.
15. Chabot S., Williams G., Hamilton M., Sutherland G., Yong V.W. Mechanisms of IL-10 production in human microglia-T cell interaction. J. Immunol. 162:1999;6819.
16. Boyden A., Button E., Germerog D. Precipitin testing with special Reference to the measurement of turbidity. J. Immunol. 57:1947;211.
17. Hellsing K. The effects of different polymers for enhancement of the antigen-antibody reaction as measured with nephelometry. Protides of the Biological Fluids. 23:1973;259.
18. SYNCHRON LX Systems Chemistry Information Manual 962288. 2000;. May.
19. Insightful S-plus user's guide for windows. 2001;371-372. July.
20. Cleveland W.S. Robust locally weighted regression and smoothing scatterplots. J. Am. Stat. Assoc. 74:1979;829.
21. Zacharski L.R., Chow B., Lavori P.W., Howes P.S., Bell M.R., DiTommasso M.A., Carnegie N.M., Bech F., Amidi M., Muluk S. The iron (Fe) and atherosclerosis study (FeAST) A pilot study of body iron stores in peripheral vascular disease . Am. Heart J. 139:2000;337.
22. Jovinge S., Hamsten A., Tornvall P., Proudler A., Bavenholm P., Ericsson C.G., Godsland I., de Faire U., Nilsson J. Evidence for a role of tumor necrosis factor alpha in disturbances of triglycerides and glucose metabolism predisposing to coronary heart disease. Metabolism. 47:1998;113.
23. Blann A.D., McCollum C.N. Increased levels of tumor necrosis factor receptors in atherosclerosis no clear relationship with levels of tumor necrosis factor . Inflammation. 22:1998;483.
24. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342:2000;836.
25. Seljeflot I., Johansen O., Arnessen H., Eggesbo J.B., Westvik A.B., Kierulf P. Procoagulant activity and cytokine expression in whole blood cultures supplemented with omega-3-fatty acids. Thromb. Haemost. 81:1999;566.
26. Fiotti N., Giansante C., Ponte E., Delbello C., Calabrese S., Zacchi T., Dobrina A., Guamieri G. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. Atherosclerosis. 145:1999;51.
27. Ridker P.M., Rifai N., Stampfer M.J., Hennekens C.H. Plasma concentration of Interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 101:2000;1767.
28. Ridker P.M., Rifai N., Pfeffer M., Sacks F., Lepage S., Braunwald E. Elevation of tumor necrosis factor alpha and increased risk of recurrent cardiac events after myocardial infarction. Circulation. 101:2000;2149.
29. Ridker P.M., Stampfer M.J., Rifai N. Novel risk factors for systemic atherosclerosis. JAMA. 285:2001;2481.
30. Zacharski L.R., Ornstein D.L., Woloshin S., Schwartz L.M. Association of age, sex, and race with body iron stores in adults Analysis of NHANES lll data . Am. Heart J. 140:2000;98.
31. Fleming D.J., Jacques P.F., Massaro J.M., D'Agostino R.B., Wilson P.W., Wood R.J. Aspirin intake and the use if serum ferritin as a measure of iron status. Am. J. Clin. Nutr. 74:2001;219.
32. Brown A.S., Hong Y., deBelder A., Beacon H., Beeso J., Sherwood R., Edmonds M., Martin J.F., Erusalimsky J.D. Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 17:1997;802.
33. Vasse M., Paysant J., Soria J., Collet J.P., Vannier J.P., Soria C. Regulation of fibrinogen biosynthesis by cytokines, consequences on the vascular risk. Haemostasis. 26:(Suppl 4):1996;3319.
34. Mallat Z., Besnard S., Duriez M., Deleuze V., Emmanuel F., Bureau M. F, Soubrier F., Esposito B., Duez H., Fievet C., Staels B., Duverger N., Scherman D., Tedgui A. Protective role of interleukin-10 in atherosclerosis. Circ. Res. 85:1999;e17.
35. Smith D.A., Irving S.D., Sheldon J., Cole D., Kaski J.C. Serum levels of the anti-inflammatory cytokine interleukin-10 decreased in patients with unstable angina. Circulation. 1104:2001;746.
36. Malone D., Napolitano L.M., Genuit T., Bochicchio G.V., Kole K., Scalea T.M. Total cytokine immunoassay a more accurate measurement of cytokine measurement . J. Trauma. 50:2001;821.
37. Wiederman C.J., Kiechl S., Schratzberger P., Dunzendorfer S., Weiss G., Willeit J. The role of immune activation in endotoxin-induced atherogenesis. J. Endotoxin. Res. 7:2001;322.
38. Sullivan J.L. Iron and the sex difference in heart disease risk. Lancet. 1:1981;1293.
39. Sullivan J.L. Iron therapy and cardiovascular disease. Kidney Int. 55:(Suppl):1999;S135.
40. Klipstein-Grobush K., Koster J.F., Grobbee D.E., Lindemans J., Boeing H., Hofman A., Witteman J.C. Serum ferritin and risk of myocardial infarction in the elderly the Rotterdam Study . Am J Clin Nutr. 69:1999;1231.
41. Sempos C.T., Looker A.C., Gillum R.F. Iron and heart disease The epidemiologic data . Nutr. Rev. 54:1996;73.
42. Corti M.C., Gaziano M., Hennekens C.H. Iron status and risk of cardiovascular disease. Ann. Epidemiol. 7:1997;62.
43. Sempos C.T., Looker A.C., Gillum R.E., McGee D.L., Vuong C.V., Johnson C. Serum ferritin and death from all causes and cardiovascular disease The NHANES II Mortality study . Ann. Epidemiol. 10:2000;441.
44. Haidari M., Javadi E., Sanati A., Hajilooi M., Ghanbili J. Association of increased ferritin with premature coronary stenosis in men. Clin. Chem. 47:2001;1666.
45. Tuomainen T.P., Salonen R., Nyyssonen K., Salonen J.T. Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland. B. M. J. 314:1997;793.
46. Salonen J.T., Tuomainen T.P., Salonen R., Lakka T.A., Nyyssonen K. Donation of blood is associated with reduced risk of myocardial infarction. The Kuopio Ischaemic Heart Disease Risk Factor Study. Am. J. Epidemiol. 148:1998;445.
47. Ascherio A., Rimm E.B., Giovannucci E., Willet W.C., Stampfer M.J. Blood donations and risk of coronary heart disease in men. Circulation. 103:2001;52.
48. Osler M., Milman N., Heitmann B.L. Consequences of removing iron fortification of flour on iron status among Danish adults Some longitudinal observations between 1987 and 1994 . Prev. Med. 29:1999;32.
49. Whitely W.D., Hancock W.W., Kupiec-Weginsky J.W., DeSouska M., Tilney N.L. Iron cholation suppresses mononuclear cell activation, modifies lymphocyte migration patterns and prolongs rat cardiac allograft survival in rats. Transplantation. 56:1993;1182.